Recent Updates
Recently added Catalysts
RADX Positive Sentiment Score: 70/100

BAMF Health to manufacture & dose for RAD101 Phase 2b trial

Monday, October 21, 2024 1 min read
Key Takeaway: BAMF Health has been selected to manufacture and dose for the RAD101 Phase 2b trial. This collaboration marks a significant step forward in the development of RAD101, showcasing the company's commitment to advancing its clinical programs. The trial aims to assess the efficacy and safety of RAD101 in patients.

Market Sentiment Analysis

POSITIVE FACTORS

  • BAMF Health is set to manufacture and dose for RAD101 trial.
  • The Phase 2b trial indicates progress in RAD101's development.
  • Collaboration with BAMF Health may enhance trial efficiency.

Full Press Release Details

• RAD Articles
• October 21, 2024
Loading Viewer…

More Announcements & Updates

• Announcements
• April 29, 2025
• Announcements
• November 28, 2022
• Announcements
• September 13, 2024
• Announcements
• February 14, 2023

Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)

Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026

Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs

CLINICAL UPDATE AND CAPITAL RAISING OCTOBER 20th, 2025

Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)

Dr. Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

• RAD Presentation June 2026
• Zacks Small-Cap Research 2026
• RAD Presentation March 2026
• Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)
• Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026
• Zacks Small-Cap Research

Frequently Asked Questions

What is the purpose of the RAD101 Phase 2b trial?

The RAD101 Phase 2b trial aims to evaluate the efficacy and safety of RAD101 in patients.

Who is manufacturing for the RAD101 trial?

BAMF Health has been selected to manufacture and dose for the RAD101 Phase 2b trial.

What does the collaboration with BAMF Health signify?

The collaboration indicates a significant advancement in the development of RAD101.

Tags: RADX Viatris Investor Conferences Healthcare BAMF Health RAD101 Phase 2b trial clinical trial
Last updated: Oct 21, 2024